L-carnitine (LC) is a pharmaceutical formulation with multiple clinical applications, including: Correcting carnitine deficiency in patients with chronic fatigue syndrome Dialysis patients Enhancing exercise tolerance in patients with angina Correcting muscle weakness Growth retardation Motor skill impairment in children and premature infants Treatment of toxicity caused by anthracyclines and sodium valproate Acetyl-L-carnitine (ALC) Acetyl-L-carnitine (ALC) is the esterified form of LC, synthesized by the ALC transferase enzyme in the brain, liver, and kidneys
There are reports that an overload of glutathione would encourage inflammatory diseases by excessively stimulating immune cells
No flavour, sweeteners or fillers
Formulary changes are common
This discussion compares tripeptides, exemplified by the well-studied GHK, with larger peptides such as the cyclic heptapeptide CyRL-QN15, the human cathelicidin-derived antimicrobial peptide LL-37, and the peptide Andersonin W-1 (AW1), containing 7, 37, and 72 amino acids, respectively [25, 67, 68]
Code Availability No custom code was developed for this review article